Vaccines -- A Community Role for HIV
The Time to Get Involved Is Now
While the reality of having an effective vaccine to prevent HIV infections is probably still many years away, the effort to find one is growing even as you read this article. More experimental vaccines are entering into clinical trials today, with many more products coming down the pipeline.
As exciting as it is to have a variety of different experimental AIDS vaccines in development, one of the greatest challenges still to overcome has to do with people just like you. Without the involvement of ordinary, everyday people, HIV vaccine research doesn't stand a chance. This is because the only way we will be able to discover what will protect a person from HIV is to test experimental vaccines in people.
So what are the obstacles to getting people into clinical trials? A recent study by the National Institutes of Health found that one out of five persons surveyed believed that an HIV vaccine already exists, but is being kept secret. About half of those surveyed had not heard anything about HIV vaccine research over the past year.
What does all this mean? That few people are aware of the current effort to develop an HIV vaccine, which would help to explain the challenge of finding people who are willing to volunteer to be in clinical trials. After all, how can people volunteer for something they don't even know is going on?
Ironically, a vaccine trial needs to enroll thousands of people and for more than three years, thousands more people (and more years) than is needed to bring an HIV drug to market!
Clinical Trials Around the World
More than 60 AIDS vaccines are in development right now (visit www.avac.org). More than 25 are entering or about to enter Phase I and II trials. Currently vaccine clinical trials are being conducted (or will soon be conducted) all over the world.
In the continental U.S., HIV vaccine clinical trials sites include Providence, Rhode Island; Rochester and New York City; Boston; Chicago; Baltimore; Birmingham, Alabama; Nashville; San Francisco; Seattle; and St. Louis, Missouri.
Around the world, vaccine clinical trial sites include Canada, Haiti, the Dominican Republic, Puerto Rico, Trinidad and Tobago, Peru, Brazil, Finland, the United Kingdom, the Netherlands, Belgium, Germany, France, Switzerland, Italy, Cameroon, Rwanda, Uganda, Kenya, Tanzania, Malawi, Zambia, Botswana, South Africa, Russia, India, Thailand, China and Australia.
Current research efforts have raised issues that must be addressed today. Understanding these issues and preparing for them proactively will speed up the development of an AIDS vaccine. Here are a few issues that the public needs to be aware of.
But the community first requires education about clinical research and participant protections. The public must be informed about the potential of an AIDS vaccine, as well as the risks and benefits of participating in clinical research. Also, trial participants and their loved ones must be assured that their rights and health are being championed throughout this process.
Past abuses in biomedical research, such as the Tuskegee experiments, remain fresh in the memory of many people. Furthermore, examples like Tuskegee also illustrate some of the reasons certain communities have greater distrust of biomedical research than others.
After Tuskegee, several safeguards were put into place to ensure that such abuses are not repeated and that research benefits are shared equally across communities. Community involvement is one of the safeguards. This is one reason why we so urgently need to provide the community with education on clinical research.
Addressing issues of racism, sexism, ageism and classism will have a direct impact on which communities step forward to participate in clinical research. Inclusion of diverse communities will not only help ensure that an AIDS vaccine works for multiple communities, but also that diverse communities accept the vaccine because they were involved in the development of it.
Making a difference in terms of developing an HIV vaccine can be as simple as sharing what you read in this article with a couple of your friends. Get conversations going so people you know are aware of current research and how to get involved.
If there are trials in your area, you or people you know could join a trial or you could join a Community Advisory Board (CAB) at the study institution and lend your knowledge and time to the effort. You could help just by making sure people know the truth about HIV vaccine research. Sometimes it is just the little things that can make a huge difference.
Got a comment on this article? Write to us at firstname.lastname@example.org.
One Step Forward: Merck Vaccine Moves Forward With Efficacy Trial, While Special Committee Tries to Salvage Thai Study
ADVAX, New DNA Vaccine in Human Trial; HIV-Negative Volunteers Needed in New York City or Rochester, NY Areas
This article was provided by Test Positive Aware Network. It is a part of the publication Positively Aware. Visit TPAN's website to find out more about their activities, publications and services.